312 related articles for article (PubMed ID: 33036018)
21. Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase Genes in Clinical Isolates of Escherichia coli in Myanmar: Dominance of bla
Aung MS; San N; Maw WW; San T; Urushibara N; Kawaguchiya M; Sumi A; Kobayashi N
Microb Drug Resist; 2018 Nov; 24(9):1333-1344. PubMed ID: 29565227
[TBL] [Abstract][Full Text] [Related]
22. Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.
Gauthier L; Dortet L; Cotellon G; Creton E; Cuzon G; Ponties V; Bonnin RA; Naas T
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866863
[TBL] [Abstract][Full Text] [Related]
23.
Roer L; Overballe-Petersen S; Hansen F; Schønning K; Wang M; Røder BL; Hansen DS; Justesen US; Andersen LP; Fulgsang-Damgaard D; Hopkins KL; Woodford N; Falgenhauer L; Chakraborty T; Samuelsen Ø; Sjöström K; Johannesen TB; Ng K; Nielsen J; Ethelberg S; Stegger M; Hammerum AM; Hasman H
mSphere; 2018 Jul; 3(4):. PubMed ID: 30021879
[No Abstract] [Full Text] [Related]
24. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
Ma L; Siu LK; Lin JC; Wu TL; Fung CP; Wang JT; Lu PL; Chuang YC
BMC Infect Dis; 2013 Dec; 13():599. PubMed ID: 24354657
[TBL] [Abstract][Full Text] [Related]
25. Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. coli ST131 and non-ST131 isolates from Iran.
Hojabri Z; Darabi N; Arab M; Saffari F; Pajand O
BMC Microbiol; 2019 May; 19(1):117. PubMed ID: 31146674
[TBL] [Abstract][Full Text] [Related]
26. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
[TBL] [Abstract][Full Text] [Related]
27. Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.
Mahalingam N; Manivannan B; Khamari B; Siddaramappa S; Adak S; Bulagonda EP
Med Princ Pract; 2018; 27(5):428-435. PubMed ID: 29739004
[TBL] [Abstract][Full Text] [Related]
28. Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015-2017.
Li F; Ye K; Li X; Ye L; Guo L; Wang L; Yang J
BMC Microbiol; 2021 Sep; 21(1):248. PubMed ID: 34535075
[TBL] [Abstract][Full Text] [Related]
29. Characterization of an International High-Risk Escherichia coli ST410 Clone Coproducing NDM-5 and OXA-181 in a Food Market in China.
He WY; Lv LC; Pu WX; Gao GL; Zhuang ZL; Lu YY; Zhuo C; Liu JH
Microbiol Spectr; 2023 Jun; 11(3):e0472722. PubMed ID: 37166308
[TBL] [Abstract][Full Text] [Related]
30. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48.
Ortega A; Sáez D; Bautista V; Fernández-Romero S; Lara N; Aracil B; Pérez-Vázquez M; Campos J; Oteo J;
J Antimicrob Chemother; 2016 Aug; 71(8):2131-8. PubMed ID: 27147304
[TBL] [Abstract][Full Text] [Related]
31. High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
Lunha K; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Wonglakorn L; Saenjamla P; Chaimanee P; Angkititrakul S; Chetchotisakd P
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):221-6. PubMed ID: 27041106
[TBL] [Abstract][Full Text] [Related]
32. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.
Kaase M; Schimanski S; Schiller R; Beyreiß B; Thürmer A; Steinmann J; Kempf VA; Hess C; Sobottka I; Fenner I; Ziesing S; Burckhardt I; von Müller L; Hamprecht A; Tammer I; Wantia N; Becker K; Holzmann T; Furitsch M; Volmer G; Gatermann SG
Int J Med Microbiol; 2016 Sep; 306(6):415-20. PubMed ID: 27237423
[TBL] [Abstract][Full Text] [Related]
33. Escherichia coli colonizing healthy children in Tunisia: High prevalence of extra-intestinal pathovar and occurrence of non-extended-spectrum-β-lactamase-producing ST131 clone.
Ferjani S; Saidani M; Maamar E; Harbaoui S; Hamzaoui Z; Hosni H; Amine FS; Boubaker IBB
Int J Antimicrob Agents; 2018 Dec; 52(6):878-885. PubMed ID: 30036576
[TBL] [Abstract][Full Text] [Related]
34. Early emergence of OXA-181-producing Escherichia coli ST410 in China.
Qin S; Cheng J; Wang P; Feng X; Liu HM
J Glob Antimicrob Resist; 2018 Dec; 15():215-218. PubMed ID: 30393155
[TBL] [Abstract][Full Text] [Related]
35. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
[TBL] [Abstract][Full Text] [Related]
36. Clonal diversity and genetic profiling of antibiotic resistance among multidrug/carbapenem-resistant Klebsiella pneumoniae isolates from a tertiary care hospital in Saudi Arabia.
Zaman TU; Alrodayyan M; Albladi M; Aldrees M; Siddique MI; Aljohani S; Balkhy HH
BMC Infect Dis; 2018 May; 18(1):205. PubMed ID: 29724185
[TBL] [Abstract][Full Text] [Related]
37. Extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy humans in Mexico, including subclone ST131-B2-O25:H4-H30-Rx.
Cortés-Cortés G; Lozano-Zarain P; Torres C; Alonso CA; Ríos-Torres AM; Castañeda M; López-Pliego L; Navarro A; Del Carmen Rocha-Gracia R
J Glob Antimicrob Resist; 2017 Jun; 9():130-134. PubMed ID: 28552831
[TBL] [Abstract][Full Text] [Related]
38. First report of an Escherichia coli strain from swine carrying an OXA-181 carbapenemase and the colistin resistance determinant MCR-1.
Pulss S; Semmler T; Prenger-Berninghoff E; Bauerfeind R; Ewers C
Int J Antimicrob Agents; 2017 Aug; 50(2):232-236. PubMed ID: 28666753
[TBL] [Abstract][Full Text] [Related]
39. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.
Yasir M; Ajlan AM; Shakil S; Jiman-Fatani AA; Almasaudi SB; Farman M; Baazeem ZM; Baabdullah R; Alawi M; Al-Abdullah N; Ismaeel NA; Shukri HA; Azhar EI
Sci Rep; 2018 Oct; 8(1):14847. PubMed ID: 30287889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
